Researchers provide convincing evidence that an in-house developed blood test for Alzheimer's disease can detect the disease early and track its course, which has major implications for a potential use in clinical practice and treatment trials.
from Healthy Aging News -- ScienceDaily https://ift.tt/39F8JSh
No comments:
Post a Comment